This inventor holds 1 USPTO granted patent. Top assignees: Sanofi, Other. Active years: 1997.
Company Filing History:
1 out of 1,543 
1 out of 834,411 Years Active: 1997
Title: Paul Ritzenthaler: Innovator in Nucleic Acid Technology
Introduction
Paul Ritzenthaler is a notable inventor based in Castanet, France. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid sequences. His work has implications for various applications, including genetic engineering and biotechnology.
Latest Patents
Ritzenthaler holds a patent for a nucleic acid sequence and plasmids comprising at least one phage. This invention relates to a DNA sequence of approximately 1.9 kb that includes at least one phage resistance mechanism. The sequence is derived from the HindIII-HindIII DNA sequence of 3.3 kb found in the strain Lactococcus lactis ssp lactis, which has been deposited in the CNCM under no. I-945, using the PCR method. He has 1 patent to his name.
Career Highlights
Throughout his career, Ritzenthaler has worked with prominent companies, including Sanofi. His expertise in molecular biology has allowed him to contribute to various projects that advance the understanding and application of genetic materials.
Collaborations
Ritzenthaler has collaborated with notable colleagues such as Elisabeth Remy and Fabien Prevots. These partnerships have fostered innovation and have been instrumental in the development of his research.
Conclusion
Paul Ritzenthaler is a distinguished inventor whose work in nucleic acid technology has made a lasting impact in the field. His contributions continue to influence advancements in biotechnology and genetic research.